Duragesic Public Health Advisory Follows Palladone Withdrawal
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is investigating reports of deaths associated with overdoses of the fentanyl patch (J&J’s Duragesic and generics). As with Purdue’s opioid Palladone, alcohol consumption is cited as a possible factor in increased fentanyl release or effect.
You may also be interested in...
Limits Of FDA’s Risk Management Practices Shown In Renewed Duragesic Warnings
Fentanyl patch will get stronger labeling and a patient MedGuide, but FDA opts against a more interventionist approach as it issues its second public health advisory in two years about the risk of death.
Limits Of FDA’s Risk Management Practices Shown In Renewed Duragesic Warnings
Fentanyl patch will get stronger labeling and a patient MedGuide, but FDA opts against a more interventionist approach as it issues its second public health advisory in two years about the risk of death.
Lavipharm Transdermal Fentanyl Patch Generic Approved By FDA
Greek drug maker said it plans to launch the generic of J&J/Alza's Duragesic patch with a U.S. partner, which it has yet to announce.